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Anti TNF-α therapy might be responsible for an increased incidence of varicocele
in patients with ankylosing spondylitis
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Aim: To evaluate the effects of anti-tumor necrosis factor-alpha (TNF-α) therapy on the frequency of varicocele in patients with
ankylosing spondylitis (AS) using color Doppler ultrasound.
Materials and methods: The patients were divided into 2 groups: patients with AS who were on anti-TNF-α treatment and patients with
AS who were not regularly taking any antiinflammatory drugs. Thirty-one healthy volunteers were included as controls.
Results: Left-sided varicocele was determined in 14 patients of Group 1 (44%), 10 patients of Group 2 (33%), and 7 of the controls
(23%). There was a statistically significant difference only between Group 1 and controls (P = 0.009). However, right-sided varicocele
was determined in 12 patients of Group 1 (38%), 2 patients of Group 2 (6%), and 2 of the controls (6%) (P = 0.01 vs. Group 2, P = 0.005
vs. controls).
Conclusion: The present study shows that patients with AS who were taking anti-TNF-α therapy had an increased prevalence of rightsided and bilateral varicocele compared to patients with AS who were not taking any disease-modifying antirheumatic drugs and the
healthy control group.
Key words: Varicocele, ankylosing spondylitis, color Doppler ultrasound

1. Introduction
Ankylosing spondylitis (AS) is a chronic systemic
inflammatory disease that predominantly affects young
men (1). A combination of genetic and immune factors
is responsible for its pathogenesis; it often affects the
axial skeleton, enthesis regions, and, occasionally,
peripheral joints (2). AS may incorporate extraarticular
manifestations including vascular involvement (1,3). The
association of AS and vascular involvement is common,
but the exact causes are not fully known (3).
On the other hand, it has recently been shown that
there is a relationship between AS and the development
of varicocele (4,5). Varicocele is defined as the abnormal
dilatation and tortuosity of the pampiniform plexus veins.
It mainly occurs on the left side and can be associated
with infertility in men (6). Varicocele may be clinical
or subclinical. Clinical varicocele can be detected and
graded by physical examination (7). However, subclinical
* Correspondence: doktorlar77@hotmail.com

varicocele is not palpable and requires imaging techniques
for diagnosis, especially color Doppler ultrasound (8,9).
Color Doppler sonography is a much more reliable and
reproducible technique and is currently considered as the
gold standard for the diagnosis of varicocele (6,10). There
are 2 types of varicocele. The primary type affects nearly
one-sixth of the male population and its etiopathogenesis
is unclear (11). The secondary form of varicocele emerges
as a result of diseases that cause high pressure levels on
the testicular vein, like constipation, hydronephrosis,
neoplasms, and cirrhosis, or after abdominal operations
(12).
Tumor necrosis factor-alpha (TNF-α) is initially
synthesized by activated macrophages and T cells as a
transmembrane precursor protein. TNF-α is important
for macrophage and phagosome activation, differentiation
of monocytes to macrophages, granuloma formation,
and maintenance of granuloma integrity (13). Given the
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crucial role of TNF-α in many autoinflammatory diseases,
in order to prevent damaging the signaling pathways, a
protein-based soluble receptor antagonist and monoclonal
antibodies are used (14). TNF-α is a major cytokine that
is strongly related to disease activity and to the severity
of inflammation in patients with AS (3); therefore, TNF-α
blocking agents have become commonly used drugs in the
treatment of AS (15). However, the effects of anti-TNF-α
treatment on AS-related vascular changes has been poorly
studied (16,17), and previous results are controversial.
Since AS is associated with an increased incidence of
varicocele and vascular involvement, and TNF-α blocking
agents are commonly used in patients with AS, we aim
to evaluate the effects of anti-TNF-α therapy on the
frequency of varicocele in patients with AS using color
Doppler ultrasound.
2. Materials and methods
2.1. Study population
The study consisted of 63 adult male patients who met
the modified New York criteria for AS (18). The patients
with AS were divided into 2 groups: 1) patients with
AS who were on anti-TNF-α treatment according to
the Assessment in AS (ASAS) group guidelines (19,20)
and 2) patients with AS who were not regularly taking
any antiinflammatory drugs, including nonsteroid
antiinflammatory drugs. The patients that had a history
of atherosclerotic diseases, such as coronary artery disease
and cerebrovascular disease, or systemic diseases such as
diabetes mellitus, hypertension, and renal failure, were
excluded. Subjects receiving lipid-lowering drugs were
also excluded. A comprehensive physical examination was
applied by an expert rheumatologist, and all patients were
appraised for disease characteristics. Clinical data on AS,
such as disease duration and drug usage, were obtained
from file records and patients’ medical histories. The same
clinician evaluated the patients in terms of scrotal masses
or pain, and the subjects were clinically categorized as
having the presence or absence of varicocele. Thirty-one
healthy male volunteers with no distinct symptoms or
signs associated with genitourinary system disorders were
included as the control group. The local ethics committee
approved the study protocol, and all participants provided
written informed consent.
2.2. Sonographic assessment
A color Doppler ultrasound scanner (Aplio 80; Toshiba,
Tokyo, Japan) equipped with a 5- to 10-MHz linear
transducer was used for sonographic examination. The
diameters of the pampiniform plexus veins on the grayscale imaging were measured. The patient was placed in
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a supine position, and all measurements were made both
at rest and during the Valsalva maneuver (21). Varicocele
was diagnosed based on standard sonographic criteria,
including a pampiniform plexus vein diameter exceeding
2.5 mm at rest and a reversed flow duration of greater than
1 s during the Valsalva maneuver. For the same vessel, the
measurements were obtained 3 times using the multiplanar
scanning technique and then averaged. Sonographic
examinations were performed by 2 sonographers who
were experts on color Doppler ultrasound examination
and were unaware of the patients’ clinical data. Intraand interobserver agreement for the measurements was
evaluated in all groups. Intra- and interobserver agreement
rates for the pampiniform plexus vein measurements by
the 2 examiners were 97% and 94.5%, respectively.
2.3. Statistical analyses
The analyses were performed using SPSS 15.0 for Windows
(SPSS, Chicago, IL, USA). Categorical variables were
expressed as number and percentage, and numeric data
were expressed as mean ± SD. The groups were compared
using the chi-square test regarding categorical variables.
One-way ANOVA followed by Tukey’s test was used to
compare continuous variables. A P-value of less than 0.05
was considered significant.
3. Results
Age, duration of AS, and varicocele status of the groups
are presented in the Table. Age did not significantly differ
among the groups (30.28 ± 7.15 years for Group 1, 28
± 4.81 for Group 2, and 28.25 ± 3.59 for controls). The
disease durations were similar between the 2 AS groups
(79.6 ± 44.0 vs. 88.8 ± 34.7 months). Group 1 patients
were receiving anti-TNF-α treatment for 6 to 48 months;
however, there was no significant correlation between the
duration of the anti-TNF-α therapy and the development
of varicocele. In physical examinations, varicocele was
detected in 13 patients of Group 1 (41%), 10 patients of
Group 2 (33%), and 9 controls (29%); however, these
differences were not statistically significant. In the color
Doppler examination, left-sided varicocele was determined
in 14 patients of Group 1 (44%), 10 patients of Group 2
(33%), and 7 controls (23%). There was only a statistically
significant difference between Group 1 and the controls
(P = 0.009; Figures 1 and 2). Right-sided varicocele was
determined in 12 patients of Group 1 (38%), 2 patients of
Group 2 (6%), and 2 controls (6%) (P = 0.01 vs. Group
2, P = 0.005 vs. controls). The diameters of both left and
right pampiniform plexus veins did not significantly differ
among the groups. Similarly, reversed flows during the
Valsalva maneuver were similar among the groups.
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Table. Demographic characteristics and color Doppler findings of the groups.
Characteristics

Group 1(n = 32)

Group 2 (n = 31)

Controls (n = 31)

P

Age, years

30.28 ± 7.15

28 ± 4.81

28.25 ± 3.59

NS

Varicocele in clinical examination

13/32 (40.6%)

10/31 (32.25%)

9/31 (29.03%)

NS

Right pampiniform plexus, rest, mm

1.83 ± 0.57

1.62 ± 0.32

1.68 ± 0.67

NS

Left pampiniform plexus, rest, mm

2.24 ± 0.61

2.04 ± 0.6

1.91 ± 0.71

NS

Right pampiniform plexus, Valsalva, mm

2.28 ± 0.56

1.95 ± 0.43

2.00 ± 0.82

NS

Left pampiniform plexus, Valsalva, mm

2.75 ± 0.68

2.42 ± 0.76

2.28 ± 0.9

NS

Right sided varicocele

12/32 (37.5%)

2/31 (6.45%)

2/31 (6.45%)

0.0051,2

Left sided varicocele

14/32 (43.75%)

10/31 (32.25%)

7/31 (22.5%)

0.0091

Bilateral varicocele

11/32 (34.37%)

2/31 (6.45%)

2/31 (6.45%)

0.011,2

Color Doppler findings

Values are mean ± SD and number (percentage). NS indicates not significant (P > 0.05).
1
Between group 1 and control groups.
2
Between group 1 and group 2.

Figure 1. Varicose veins of the pampiniform plexus (arrows) in a
25-year-old male patient with ankylosing spondylitis.

Figure 2. Color and spectral Doppler images show reversed
flow during the Valsalva maneuver on left sided varicocele in a
25-year-old patient with ankylosing spondylitis.

4. Discussion
In the present study, we found that patients with AS
who were taking anti-TNF-α therapy had an increased
prevalence of right-sided and bilateral varicocele
compared to patients with AS who were not taking any
disease-modifying antirheumatic drugs and to the healthy
control group. The prevalence of left-sided varicocele was
also significantly higher in patients with AS who were
receiving anti-TNF-α therapy. The present research is a
pilot study showing a possible association between antiTNF-α therapy and the frequency of varicocele.

Varicocele is the most common reversible cause of
infertility (22,23). Anatomical variations and valvular
incompetence of testicular veins are the most common
etiological factors, with left-sided dominance (24). The
other etiological factors of varicocele are constipation,
effects of physical activity, body stature, spinal cord injury,
and rheumatologic disorders such as Behçet’s disease and
AS (5,21,25–28).
Recently, the prevalence of varicocele in patients
with AS was reported to be as high as 57% and 40%
(4,5). Although the relationship between AS and an
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increased frequency of varicocele has been reported,
the underlying mechanisms of this association have not
been clarified. Several plausible mechanisms have been
suggested regarding the increased prevalence of varicocele
in patients with AS. The first is endothelial dysfunction.
Previous studies clearly demonstrated that patients with
AS have impaired endothelial function and subclinical
atherosclerosis using carotid intima-media thickness,
brachial flow mediated dilatation, and aortic pulse valve
velocity. Microparticles, which are mainly released
from platelets, leukocytes, and endothelial cells, play an
important role in pathological processes of inflammation.
Therefore, they are considered as a surrogate marker of
endothelial dysfunction and vascular damage. It was shown
that patients with AS who are treated with biological antiTNF-α therapy have significantly reduced endothelial and
platelet microparticles (29).
The second possible mechanism is mechanical
overload. It is speculated that the presence of incompetent
valves within the spermatic vein results in retrograde
venous flow and is primarily responsible for the
development of varicocele, which is negatively affected
by the Valsalva maneuver (6). Patients with AS have weak
low back muscles due to chronic low back pain. Therefore,
it may be much more important for patients with AS to
compensate for this weakness using the Valsalva maneuver
during their daily living activities. Increased abdominal
pressure leads to a mechanical overload to the testicular
vessels and can facilitate the development of varicocele.
The third mechanism is increased oxidative stress. It
was reported that there is an association between nitric
oxide (NO) levels and frequency of varicocele (30). NO
is a water-soluble and lipid-soluble free radical that plays
an important role in the modulation of blood flow (31).
Microcirculatory stagnation of blood was found to be
associated with hypoxia in testes of men with varicocele
(32). The increase in nitric oxide synthase (NOS) activity
in varicocele seems to be a compensatory mechanism to
reduce the effect of hypoxia by increasing testicular blood
flow (33). Briefly, NO is a strong vasodilator, determining
vasodilatation and contributing to blood stasis, resulting
in the generation and progression of varicocele. Shiraishi
et al. reported a strong correlation between nitrite
concentration and the internal spermatic vein diameter
(31). Ozgocmen et al. (4) reported that NO levels in the
sera of individuals drawn from the dilated spermatic
vein were nearly 2-fold higher than in the sera from the
peripheral vein. The authors suggested that there was a
high oxidative stress due to the release of NO synthase and
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xanthine oxidase within the dilated spermatic vein and
that spermatozoa function might be adversely affected by
the rise of the NO levels in the dilated spermatic vein (34).
In another study, Mitropoulos et al. (35) proposed that the
formation of peroxynitrite from the reaction of NO with
superoxide could be a causative factor for impaired sperm
function in patients with varicocele.
TNF-α is involved in reducing vascular NO availability.
This process might be a result of the activation of
nicotinamide adenine dinucleotide phosphate (NAD[P]
H) oxidase and inducible NOS (iNOS), or the inhibition
of endothelial NOS (eNOS) activity, which causes the
induction of reactive oxygen species (36). In addition,
expression of phosphodiesterase type 5 has been shown to
be upregulated by TNF-α, which may blunt the proerectile
action of NO (37). Accordingly, it has been demonstrated
that blockage of TNF-α activity by anti-TNF-α therapy may
result in NOS expression, which causes cavernosal smooth
muscle relaxation (38). In this respect, it can be argued
that anti-TNF-α therapy induces endothelial relaxation.
In the present study, we found that anti-TNF-α therapy
was associated with increased frequency of varicocele
in patients with AS. We believe that anti-TNF-α therapy
induces endothelial eNOS activity, resulting in increased
synthesis of NO. Consequently, increased levels of NO can
augment dilatation of testicular veins and facilitate the
development of varicocele in patients with AS.
In conclusion, the present study found that patients
with AS who were receiving anti-TNF-α therapy had an
increased prevalence of right-sided and bilateral varicocele
as compared to patients with AS who were not taking any
disease-modifying antirheumatic drugs and to the healthy
control group. This pilot study shows a possible association
between anti-TNF-α therapy and the frequency of
varicocele. Further large prospective randomized studies
are needed to determine the underlying mechanisms of
the increased prevalence of varicocele and the possible
association between anti-TNF-α therapy and the frequency
of varicocele in patients with AS.
Several study limitations should be noted. The present
study had a relatively small sample size. A larger number
of subjects is needed to determine the mechanism of
varicocele formation in patients with AS who are receiving
anti-TNF-α therapy. Additionally, sperm analyses of
patients were not done. A spermiogram could have shown
a possible increased incidence of sperm abnormalities in
patients with AS and varicocele who were receiving antiTNF-α therapy.
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